Medication info
Rabazol Tablet 10 mg (Rabeprazole Sodium)

Rabazol Tablet 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Boryung Biopharma Co., Ltd.
Appearance
Pale yellow, round enteric-coated tablet
Packaging
28 tablets (14 tablets/PTP x 2)
Approval status
Active

MFDS item code 201900076 · Approved 2019.01.09 · Insurance code 670501210

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcer disease and Helicobacter pylori eradication, and Zollinger-Ellison syndrome
Who takes it
Adults
Adult dose
Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should be treated with an eradication regimen. It is recommended to administer this medicine 20 mg together with clarithromycin 500 mg and amoxicillin 1 g, twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be administered in 2 divided doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Ingredients

Manufacturer
Boryung Biopharma Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcer disease and Helicobacter pylori eradication, and Zollinger-Ellison syndrome

  • Gastric ulcers
  • duodenal ulcers
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • symptoms of gastroesophageal reflux disease
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is used for the treatment of gastric ulcers, duodenal ulcers, and erosive and ulcerative gastroesophageal reflux disease. It alleviates the symptoms of gastroesophageal reflux disease and is effective for long-term maintenance therapy. It is used in combination with antibiotics for patients with gastrointestinal ulcers caused by Helicobacter pylori infection. It also helps with conditions like Zollinger-Ellison syndrome due to excessive gastric acid secretion. This medication is used to improve and treat symptoms of various gastrointestinal disorders.

How to take

Adult dose

Gastric and duodenal ulcers: The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is usually continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, administration of 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, subsequent symptoms may be controlled, as needed, using on-demand therapy with 10 mg once daily. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients infected with Helicobacter pylori should be treated with an eradication regimen. It is recommended to administer this medicine 20 mg together with clarithromycin 500 mg and amoxicillin 1 g, twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, while the 120 mg dose should be administered in 2 divided doses of 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year.

Precautions

This medication should not be used by patients who are allergic to specific components or have had hypersensitivity reactions. Pregnant or nursing women should not take this medication. Caution is advised for patients with poor liver function or the elderly, and those with a history of drug allergies should also exercise caution. This medication may cause allergic symptoms such as skin rash, itching, or hives; if such symptoms occur, discontinue use immediately. Regular blood tests and liver function tests should be performed, and immediate action should be taken if any abnormal signs are detected. Side effects may occur in various regions such as the heart, gastrointestinal tract, or nervous system, so patients should consult medical professionals if symptoms arise. Long-term use may increase the risk of fractures, and magnesium levels should be monitored periodically. This medication may interact with other drugs, so patients should inform their healthcare provider of any other medications they are taking. Caution is advised when driving or operating machinery as drowsiness may occur. The tablets should not be chewed or crushed but swallowed whole. Keep out of reach of children and do not transfer to another container. If gastrointestinal infection symptoms or adverse reactions occur during treatment, inform healthcare professionals immediately.

Side effects

Rash, hives, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, decreased platelets, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, tachycardia, bradycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, polydipsia, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, altered taste, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, convulsions, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremors, asthenia, irritability, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, lower extremity weakness, sensory dullness, decreased grip strength, language confusion, staggering, delirium, disorientation, hypersomnia, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, decreased respiration, aspiration pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, muscle hypertonicity, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color change, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eye, abnormal vision, tinnitus, otitis media, corneal opacity, blurriness, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequent urination, dysmenorrhea, dysuria, kidney stones, uterine bleeding, polyuria, gynecomastia, elevated cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, neck stiffness, photosensitivity reactions, hangover effect, weight loss, gout, anaphylactic reaction, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, disorientation, delirium, angioedema, hypomagnesemia, decreased platelets, decreased neutrophils, vesicular skin rash, urticaria, systemic allergic reaction, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, systemic lupus erythematosus, cutaneous lupus erythematosus, halitosis, dry mouth, chest tightness, hypertriglyceridemia, hypercholesterolemia, palpitations, increased intraocular pressure, urinary tract infection

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius. This helps preserve the medication’s efficacy and safety.

Appearance and packaging

Appearance

Pale yellow, round enteric-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.